Destiny Pharma plc announced the departure of Chairman, Nick Rodgers, who has resigned to pursue other interests. Discussions with a new outside chairman are very advanced with a further announcement expected shortly.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
16.38 GBX | +3.99% | -3.65% | -76.60% |
04-25 | Norcros sells Johnson Tiles UK; Trifast trading well | AN |
04-25 | Transcript : Destiny Pharma plc, 2023 Earnings Call, Apr 25, 2024 |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-76.60% | 18.89M | |
+5.33% | 111B | |
+12.11% | 106B | |
-12.56% | 22.24B | |
-3.46% | 21.25B | |
-5.52% | 18.97B | |
-35.21% | 18.52B | |
-10.86% | 16.81B | |
+37.57% | 12.54B | |
-26.24% | 8.09B |
- Stock Market
- Equities
- DEST Stock
- News Destiny Pharma plc
- Destiny Pharma plc Announces Departure of Nick Rodgers as Chairman